🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 1b/2, open-label, non-randomized multicenter study to asses...
Status
Completed
Location
SITE-1
Start Date
2014-05
Trial ID
NCT02142049
Treatments Being Tested
Non-Hodgkin lymphoma (NHL), with high aggressiveness and mortality, is one ...
Status
Unknown
Location
Department of Hematology, Shandong Provincial Hospital
Start Date
2021-03-01
Trial ID
NCT05164770
A phase 2, multicenter, open-label, single arm clinical trial in adults wit...
Status
Completed
Location
Research Site
Start Date
2017-03-13
Trial ID
NCT03023878
Treatments Being Tested
Background: * Studies conducted at the National Cancer Institute suggest t...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2009-10-22
Trial ID
NCT01030900
This prospective feasibility study evaluates a minimal residual disease (MR...
Status
Not Yet Recruiting
Location
Fred & Pamela Buffet Cancer Center
Start Date
2026-06-12
Trial ID
NCT07517705
Treatments Being Tested
There are several treatment options for depression, including Internet-deli...
Status
Completed
Location
Karolinska Institutet
Start Date
2021-10-04
Trial ID
NCT05109741
Treatments Being Tested
This randomized phase III trial studies rituximab when given together with ...
Status
Completed
Location
Rebecca and John Moores UCSD Cancer Center
Start Date
2005-05
Trial ID
NCT00118209
Treatments Being Tested
This study will evaluate the response and long-term effects of alpha-interf...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
1995-05-05
Trial ID
NCT00001379
The goal of this clinical study is to compare the study drug, axicabtagene ...
Status
Active Not Recruiting
Location
University of Alabama Hospital
Start Date
2023-02-10
Trial ID
NCT05605899
This is a randomized, open-label, multi-center, phase 3 study evaluating th...
Status
Unknown
Location
Ru Feng
Start Date
2017-07-27
Trial ID
NCT03018626